Synlett 2009(14): 2366-2370  
DOI: 10.1055/s-0029-1217797
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of Highly Functionalized Spirobenzofuranols and Spirobenzofuranones by Baylis-Hillman Reaction

K. Karthikeyan, P. T. Perumal*
Organic Chemistry Division, Central Leather Research Institute, Adyar, Chennai 600020, India
Fax: +91(44)24911589; e-Mail: ptperumal@gmail.com;
Further Information

Publication History

Received 25 May 2009
Publication Date:
06 August 2009 (online)

Abstract

Baylis-Hillman reaction of salicylaldehydes with N-aryl/alkyl maleimides under neat conditions for the synthesis of chromenes resulted in an unusual cyclization to form spirobenzofuranol derivatives in moderate to good yield. PDC oxidation of the resultant products yielded the corresponding spirobenzofuranone derivatives.

    References and Notes

  • 1a Couladouros EA. Strongilos AT. Angew. Chem. Int. Ed.  2002,  41:  3677 ; and references therein
  • 1b Moonen K. Laureyn I. Stevens CV. Chem. Rev.  2004,  104:  6177 ; and references therein
  • 2a Lu X. Zhang C. Xu Z. Acc. Chem. Res.  2001,  34:  535 
  • 2b Dalko PI. Moisan L. Angew. Chem. Int. Ed.  2004,  43:  5138 
  • 2c Fu GC. Acc. Chem. Res.  2004,  37:  542 
  • For selected reviews, see:
  • 3a Sannigrahi M. Tetrahedron  1999,  55:  9007 
  • 3b Heathcock CH. Graham SL. Pirrung MC. Plavac F. White CT. Spirocyclic Systems, In The Total Synthesis of Natural Products   Vol. 5:  Simon J. John Wiley and Sons; New York: 1983.  p.264 
  • 4a Davies RR. Antifungal Chemotherapy   149:  Wiley & Sons; New York: 1980. 
  • 4b Pirrung MC. Brown WL. Rage S. Laughton P. J. Am. Chem. Soc.  1991,  113:  8561 
  • 4c Usegilo M. Castellano PM. Operto MA. Torres R. Kaufman TS. Bioorg. Med. Chem. Lett.  2006,  16:  5097 
  • 5a Li A. Piel J. Chem. Biol.  2002,  9:  1017 
  • 5b Tsang KY. Brimble MA. Tetrahedron  2007,  63:  6015 
  • 6a Morita K. inventors; Jpn. Patent,  6803364.  ; Chem. Abstr. 1968, 69, 58828s
  • 6b Morita K. Suzuki Z. Hirose H. Bull. Chem. Soc. Jpn.  1968,  41:  2815 
  • 6c Baylis AB, and Hillman MED. inventors; Ger. Patent,  2155113.  ; Chem. Abstr. 1972, 77, 34174q
  • 6d Hillman MED, and Baylis AB. inventors; US Patent,  3743669. 
  • For reviews, see:
  • 7a Drewes SE. Roos GHP. Tetrahedron  1988,  44:  4653 
  • 7b Basavaiah D. Rao PD. Hyma RS. Tetrahedron  1996,  52:  8001 
  • 7c Ciganek E. Org. React. (N.Y.)  1997,  51:  201 
  • 7d Langer P. Angew. Chem. Int. Ed.  2000,  39:  3049 
  • 7e Basavaiah D. Rao AJ. Satyanarayana T. Chem. Rev.  2003,  103:  811 
  • 7f Basavaiah D. Rao KV. Reddy RJ. Chem. Soc. Rev.  2007,  36:  1581 
  • 7g Singh V. Batra S. Tetrahedron  2008,  64:  4511 
  • 7h DeClerck V. Martinez J. Lamaty F. Chem. Rev.  2009,  109:  1 
  • 8a Price KE. Broadwater SJ. Jung HM. McQuade DT. Org. Lett.  2005,  7:  147 
  • 8b Aggarwal VK. Fulford SY. Lloyd-Jones GC. Angew. Chem. Int. Ed.  2005,  44:  1706 
  • 8c Price KE. Broadwater SJ. Walker BJ. McQuade DT. J. Org. Chem.  2005,  70:  3980 
  • 9a Santos LS. Pavam CH. Almeida WP. Coelho F. Eberlin MN. Angew. Chem. Int. Ed.  2004,  43:  4330 
  • 9b Krafft ME. Haxell TFN. Seibert KA. Abboud KA. J. Am. Chem. Soc.  2006,  128:  4174 
  • 10a Iwabuchi Y. Nakatani M. Yokoyama N. Hatakeyama S. J. Am. Chem. Soc.  1999,  121:  10219 
  • 10b Yang K.-S. Lee W.-D. Pan J.-F. Chen K. J. Org. Chem.  2003,  68:  915 
  • 10c Imbriglio JE. Vasbinder MM. Miller SJ. Org. Lett.  2003,  5:  3741 
  • 10d McDougal NT. Schaus SE. J. Am. Chem. Soc.  2003,  125:  12094 
  • 10e Wang J. Li H. Yu X. Zu L. Wang W. Org. Lett.  2005,  7:  4293 
  • 10f Xu J. Guan Y. Yang S. Ng Y. Peh G. Tan C.-H. Chem. Asian J.  2006,  1:  724 
  • 10g Berkessel A. Roland K. Neudörfl JM. Org. Lett.  2006,  8:  4195 
  • 10h Nakano A. Takahashi K. Ishihara J. Hatakeyama S. Org. Lett.  2006,  8:  5357 
  • 11a Zhang C. Lu X. J. Org. Chem.  1995,  60:  2906 
  • 11b Xu Z. Lu X. J. Org. Chem.  1998,  63:  5031 
  • 11c Zhu X.-F. Lan J. Kwon O. J. Am. Chem. Soc.  2003,  125:  4716 
  • 11d Zhao G.-L. Huang J.-W. Shi M. Org. Lett.  2003,  5:  4737 
  • 12a Kaye PT. Musa MA. Nocanda XW. Robinson RS. Org. Biomol. Chem.  2003,  1:  1133 
  • 12b Lesch B. Torang J. Vanderheiden S. Bräse S. Adv. Synth. Catal.  2005,  347:  555 
  • 12c Shi Y.-L. Shi M. Org. Lett.  2005,  7:  3057 
  • 12d Shi Y.-L. Shi M. Synlett  2005,  2623 
  • 12e Zhao G.-L. Shi Y.-L. Shi M. Org. Lett.  2005,  7:  4527 
  • 12f Govender T. Hojabri L. Moghaddam FM. Arvidsson PI. Tetrahedron: Asymmetry  2006,  17:  1763 
  • 12g Shi M. Dai L.-Z. Shi Y.-L. Zhao G.-L. Adv. Synth. Catal.  2006,  348:  967 
  • 12h Shi Y.-L. Shi M. Chem. Eur. J.  2006,  12:  3374 
  • 12i Guo Y.-W. Shi Y.-L. Li H.-B. Shi M. Tetrahedron  2006,  62:  5875 
  • 12j Sundén H. Ibrahem I. Zhao G.-L. Eriksson L. Córdova A. Chem. Eur. J.  2007,  13:  574 
  • 12k Li H. Wang J. E-Nunu T. Zu L. Jiang W. Wei S. Wang W. Chem. Commun.  2007,  507 
  • 12l Dai L.-Z. Shi Y.-L. Zhao G.-L. Shi M. Chem. Eur. J.  2007,  13:  3701 
  • 12m Shi M. Qi M.-J. Tetrahedron  2007,  63:  10415 
  • 13a Lesch B. Bräse S. Angew. Chem. Int. Ed.  2003,  43:  115 
  • 13b Nising CF. Ohhemüller UK. Friedrich A. Lesch B. Steiner J. Schnöckel H. Nieger M. Bräse S. Chem. Eur. J.  2006,  12:  3647 
  • 13c Ohhemüller UK. Nising CF. Nieger M. Bräse S. Eur. J. Org. Chem.  2006,  1535 
  • 13d Nising CF. Ohhemüller UK. Bräse S. Angew. Chem. Int. Ed.  2006,  45:  307 
  • 13e Sosnovskikh VY. Korotaev VY. Chizhov DL. Kutyashev IB. Yachevskii DS. Kazheva ON. Dyachenko OA. Charushin VN. J. Org. Chem.  2006,  71:  4538 
  • 13f Kaye PT. Musa MA. Nocanda XW. Synthesis  2003,  531 
  • 13g Kaye PT. Musa MA. Synth. Commun.  2003,  33:  1755 
  • 13h Lee KY. Kim JM. Kim JN. Bull. Korean Chem. Soc.  2003,  24:  17 
  • 13i Lee KY. Kim JM. Kim JN. Synlett  2003,  357 
  • 13j Hong WP. Lee K.-J. Synthesis  2005,  33 
  • 13k Gérard EMC. Sahin H. Encinas A. Bráse S. Synlett  2008,  2702 
  • 16 D’Auria M. Piancatelli G. Scettri A. Tetrahedron  1980,  36:  3071 
14

Experimental Procedure for the Synthesis of Spiroben-zofuranol 3 and 4:
A mixture of salicylaldehyde 1 (1.62 mmol, 1.2 equiv),
N-substituted maleimide 2 (1.35 mmol, 1.0 equiv) and DABCO (30 mol%) was stirred at 70 ˚C under neat conditions for 1-2 h. The residue was dissolved in EtOAc (20 mL) and given a dilute HCl wash (1 × 20 mL) and H2O wash (2 × 20 mL). The EtOAc layer was dried over anhyd Na2SO4 and removal of solvent under reduced pressure gave a crude product, which was purified by flash column chromatography with EtOAc-PE (20:80) as eluent to obtain spirobenzofuranols 3 and 4. Spectral Data of Compound 3b: colorless solid; mp 162-164 ˚C; R f 0.33 (50% EtOAc-PE). IR: 3450, 2918, 1785, 1698, 1623, 1441, 1195 cm. ¹H NMR (500 MHz, DMSO-d 6): δ = 1.26 (t, 3 H, J = 6.9 Hz), 2.85 (s, 3 H), 2.88 (d, 1 H, J = 18.3 Hz), 3.37 (d, 1 H, J = 18.3 Hz), 3.98-4.03 (m, 2 H), 5.19 (d, 1 H, J = 6.9 Hz), 6.17 (d, 1 H, J = 6.9 Hz), 6.87-6.95 (m, 3 H). ¹³C NMR (125 MHz, DMSO-d 6): δ = 15.1, 25.1, 35.0, 64.3, 73.8, 89.6, 114.5, 117.9, 122.6, 129.9, 143.7, 147.4, 174.3, 176.2. HRMS: m/z calcd for C14H15NO5: 277.0952; found: 277.0957.

15

Crystallographic data of the compound 3a in this paper have been deposited with the Cambridge Crystallographic Data Centre as supplemental publication no. CCDC-724171. Copies of the data can be obtained, free of charge on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK [fax: +44 (1223)336033 or email: deposit@ccdc.cam.ac.uk].

17

Experimental Procedure for the Synthesis of Spiroben-zofuranone 9:
A mixture of salicylaldehyde 1 (1.62 mmol, 1.2 equiv),
N-substituted maleimide 2 (1.35 mmol, 1.0 equiv) and DABCO (30 mol%) was stirred under neat conditions at 70 ˚C for 1-2 h. After the formation of spirobenzofuranols 3 and 4, CH2Cl2 and PDC (1.2 equiv) were added to the reaction mixture and the mixture was refluxed. After 1 h the reaction mixture was filtered on a celite pad. The filtrate was concentrated, poured into H2O, and extracted with EtOAc (3 × 20 mL). The organic layer was dried over anhyd Na2SO4 and removal of solvent under reduced pressure gave a crude product, which was purified by column chromatography with EtOAc-PE (10:90) as eluent to obtain the spirobenzofuranone 9. Spectral Data of Compound 9b: colorless solid; mp 136-138 ˚C; R f 0.46 (40% EtOAc-PE). IR: 2930, 1715, 1602, 1383, 1159 cm. ¹H NMR (500 MHz, CDCl3): δ = 1.47 (t, 3 H, J = 6.9 Hz), 3.06 (s, 3 H), 3.13 (d, 1 H, J = 18.4 Hz), 3.20 (d, 1 H, J = 17.6 Hz), 4.16 (q, 2 H, J = 6.9 Hz), 7.08 (t, 1 H, J = 7.6 Hz), 7.17 (d, 1 H, J = 8.4 Hz), 7.24 (t, 1 H, J = 7.6 Hz). ¹³C NMR (125 MHz, CDCl3): δ = 14.8, 25.9, 37.4, 65.0, 86.9, 115.9, 120.4, 120.8, 124.2, 145.9, 163.1, 170.3, 172.5, 196.2. MS: m/z = 276 [M+ + 1]. Anal. Calcd for C14H13NO5 (275.06): C, 61.09; H, 4.76; N, 5.09. Found: C, 61.17; H, 4.78; N, 5.01.